1. Home
  2. AVXL vs LFCR Comparison

AVXL vs LFCR Comparison

Compare AVXL & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.56

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Logo Lifecore Biomedical Inc.

LFCR

Lifecore Biomedical Inc.

N/A

Current Price

$4.59

Market Cap

190.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVXL
LFCR
Founded
2004
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
190.9M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
AVXL
LFCR
Price
$3.56
$4.59
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$22.00
$6.00
AVG Volume (30 Days)
842.7K
122.1K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$557,559,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.36
52 Week Low
$2.26
$3.63
52 Week High
$10.40
$8.98

Technical Indicators

Market Signals
Indicator
AVXL
LFCR
Relative Strength Index (RSI) 64.61 50.36
Support Level $3.53 $4.63
Resistance Level $3.76 $5.21
Average True Range (ATR) 0.16 0.26
MACD -0.00 0.01
Stochastic Oscillator 98.98 46.10

Price Performance

Historical Comparison
AVXL
LFCR

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: